AAAAAA

   
Results: 1-14 |
Results: 14

Authors: McClellan, WM Goldman, RS
Citation: Wm. Mcclellan et Rs. Goldman, Continuous quality improvement in dialysis units: Basic tools, ADV RENAL R, 8(2), 2001, pp. 95-103

Authors: Rocco, MV Bedinger, MR Milam, R Greer, JW McClellan, WM Frankenfield, DL
Citation: Mv. Rocco et al., Duration of dialysis and its relationship to dialysis adequacy, anemia management, and serum albumin level, AM J KIDNEY, 38(4), 2001, pp. 813-823

Authors: Freedman, BI Soucie, JM Kenderes, B Krisher, J Garrett, LE Caruana, RJ McClellan, WM
Citation: Bi. Freedman et al., Family history of end-stage renal disease does not predict dialytic survival, AM J KIDNEY, 38(3), 2001, pp. 547-552

Authors: McClellan, WM Frankenfield, DL Wish, JB Rocco, MV Johnson, CA Owen, WF
Citation: Wm. Mcclellan et al., Subcutaneous erythropoietin results in lower dose and equivalent hematocrit levels among adult hemodialysis patients: Results from the 1998 end-stagerenal disease core indicators project, AM J KIDNEY, 37(5), 2001, pp. NIL_23-NIL_30

Authors: Rocco, MV Frankenfield, DL Frederick, PR Pugh, J McClellan, WM Owen, WF
Citation: Mv. Rocco et al., Intermediate outcomes by race and ethnicity in peritoneal dialysis patients: Results from the 1997 ESRD Core Indicators project, PERIT DIA I, 20(3), 2000, pp. 328-335

Authors: Kohler, KA McClellan, WM Ziemer, DC Kleinbaum, DG Boring, JR
Citation: Ka. Kohler et al., Risk factors for microalbuminuria in Black Americans with newly diagnosed type 2 diabetes, AM J KIDNEY, 36(5), 2000, pp. 903-913

Authors: Freedman, BI Soucie, JM Chapman, A Krisher, J McClellan, WM
Citation: Bi. Freedman et al., Racial variation in autosomal dominant polycystic kidney disease, AM J KIDNEY, 35(1), 2000, pp. 35-39

Authors: Rocco, M Soucie, JM Pastan, S McClellan, WM
Citation: M. Rocco et al., Peritoneal dialysis adequacy and risk of death, KIDNEY INT, 58(1), 2000, pp. 446-457

Authors: McClellan, WM Krisher, JO
Citation: Wm. Mcclellan et Jo. Krisher, Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance, KIDNEY INT, 57, 2000, pp. S7-S13

Authors: Bright, RA Torrence, ME Daley, WR McClellan, WM
Citation: Ra. Bright et al., Preliminary survey of the occurrence of anaphylactoid reactions during haemodialysis, NEPH DIAL T, 14(3), 1999, pp. 799-800

Authors: Flanders, WD Tucker, G Krishnadasan, A Martin, D Honig, E McClellan, WM
Citation: Wd. Flanders et al., Validation of the pneumonia severity index - Importance of study-specific recalibration, J GEN INT M, 14(6), 1999, pp. 333-340

Authors: McClellan, WM Frankenfield, DL Frederick, PR Flanders, WD Alfaro-Correa, A Rocco, M Helgerson, SD
Citation: Wm. Mcclellan et al., Can dialysis therapy be improved? A report from the ESRD Core Indicators Project, AM J KIDNEY, 34(6), 1999, pp. 1075-1082

Authors: Frankenfield, DL Rocco, MV Frederick, PR Pugh, J McClellan, WM Owen, WF
Citation: Dl. Frankenfield et al., Racia/ethnic analysis of selected intermediate outcomes for hemodialysis patients: Results from the 1997 ESRD Core Indicators Project, AM J KIDNEY, 34(4), 1999, pp. 721-730

Authors: Frankenfield, DL McClellan, WM Helgerson, SD Lowrie, EG Rocco, MV Owen, WF
Citation: Dl. Frankenfield et al., Relationship between urea reduction ratio, demographic characteristics, and body weight for patients in the 1996 national ESRD core indicators project, AM J KIDNEY, 33(3), 1999, pp. 584-591
Risultati: 1-14 |